ACDN-01 / Ascidian Therap - LARVOL DELTA

Study to Evaluate ACDN-01 in ABCA4-related Retinopathy (STELLAR) (clinicaltrials.gov) - P1/2 | N=13 | Recruiting | Sponsor: Ascidian Therapeutics, Inc

New P1/2 trial • Age-related Macular Degeneration • Inherited Retinal Dystrophy • Macular Degeneration • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa